Rev. ed. of: Bipolar disorder: treatment and management / by Trisha Suppes, Paul E. Keck Jr. c2005.

This guideline covers recognising, assessing and treating bipolar disorder (formerly known as manic depression) in children, young people and adults. The recommendations apply to bipolar I, bipolar II, mixed affective and rapid cycling disorders. It aims to improve access to treatment and quality of life in people with bipolar disorder.

Bipolar disorder, or manic depression, is characterised by episodes of pathological mood states. The two poles are mania (with a predominant elated or irritable mood) and depression (with feelings of sadness, anxiety, guilt or hopelessness) but mixed states frequently occur. Episodes can last for many months and profoundly affect physical health, relationships and careers. Since diagnosis and management are difficult, this practical guide provides an overview of the disorder and detailed guidelines for treating the illness throughout its stages, from authors internationally renowned for their work in bipolar disorder. Also discussed are disease theories, mechanisms and key clinical trials, as well as chapters devoted to psychosocial treatments, substance misuse and insights from 'lived experience'. In-depth analyses of selected population groups, including youth, the elderly and women, complement guidelines for clinical approaches in managing bipolar disorder. Comprehensive and detailed, this guide will prove invaluable to clinicians, general practitioners, psychiatrists and psychologists.

The Maudsley® Prescribing Guidelines in Psychiatry The new edition of the world-renowned reference guide on the use of medications for patients presenting with mental health problems The Maudsley Prescribing Guidelines in Psychiatry is the essential evidence-based handbook on the safe and effective prescribing of psychotropic agents. Covering both common and complex prescribing situations encountered in day-to-day clinical practice, this comprehensive resource provides expert guidance on drug choice, minimum and maximum doses, adverse effects, switching medications, prescribing for special patient groups, and more. Each clear and concise chapter includes an up-to-date reference list providing easy access to the evidence on which the guidance is based. The fourteenth edition has been fully updated to incorporate the latest available research, the most recent psychotropic drug introductions, and all psychotropic drugs currently used in the UK, USA, Canada, Australia, New Zealand, and Japan. Several new sections cover topics such as deprescribing of major psychiatric drugs, prescribing psychotropics at the end of life, the treatment of agitated delirium, the genetics of clozapine prescribing, the use of weekly penfluridol, and the treatment of psychotropic withdrawal. Featuring contributions by an experienced team of psychiatrists and specialist pharmacists, the new edition of The Maudsley Prescribing Guidelines in Psychiatry: Provides succinct coverage of drug treatment of psychiatric conditions and formulating prescribing policy in mental health Covers a wide range of psychiatric conditions including schizophrenia, bipolar disorder, depression and anxiety, borderline personality, eating disorders, and many others Provides advice on prescribing for children and adolescents, older people, pregnant women, and other special patient groups Offers new sections on genetic prescribing, long-acting injectable formulations, ketamine administration and uses, and dopamine super-sensitivity Includes referenced information on off-label prescribing, potential interactions with other substances such as alcohol, tobacco, and caffeine, and treating patients with comorbid physical conditions Whether in the doctor’s office, in the clinic, or on the ward, The Maudsley Prescribing Guidelines in Psychiatry, Fourteenth Edition is a must-have for psychiatrists, pharmacists, neuropharmacologists, clinical psychologists, nurses, and other healthcare professionals working in mental health, as well as trainees and students in medicine, pharmacy, and nursing.

Psychosomatic diseases are a group of diseases closely related to psychosocial factors but mainly manifested by somatic symptoms, involving respiratory, digestive, endocrine, and other systems. As a result, the lack of consensus on its diagnosis has plagued clinical treatment in internal medicine, surgery, and psychiatry for decades. In recent years, research on the pathogenesis of psychosomatic diseases has made significant progress. For example, Franz Alexander believes that unresolved subconscious conflicts are the main cause of psychosomatic disorders. The subconscious psychological conflict is caused by the changes in the functional activities of the autonomic nervous system, acting on the corresponding special organs and patients with susceptible qualities. Similarly, mental and psychological factors affect gastrointestinal sensory and motor functions through the autonomic nervous system, brain-gut axis, and neuroendocrine system. Meanwhile, gastrointestinal symptoms also affect emotions and behaviors through the brain-gut axis. In addition, the Cannon-Bard theory of emotional physiology and Pavlovian theory of higher neural activity types from quantitative research methods to study the relationship between conscious psychological factors, such as emotions, and measurable physiological and biochemical changes. In clinical work, the treatment of psychosomatic diseases has gradually shifted from emphasizing physical treatment to comprehensive treatment principles, that is, taking into account the psychological and behavioral aspects of the physical treatment of the primary disease. The main purpose of physical treatment of the primary disease is to control or relieve symptoms. To consolidate the treatment of psychosomatic diseases and reduce the recurrence of psychosomatic diseases, combining physical therapy with necessary psychotherapy would potentially obtain a more comprehensive curative effect.

Building on the success of the first edition and the growth of research in the field over the past decade, this book offers an authoritative overview of the assessment, treatment, and management of violent and sexual offenders. This new and expanded edition reflects the considerable developments in research and empirical data and captures the increasing breadth of risk assessment approaches, the wider range of empirically based therapies, and the more creative means of considering management. The second edition captures key developments in this area, with new chapters drawing on a range of pressing contemporary issues, such as female offenders, Internet offenders, terrorists, young people involved in harmful sexual behaviour, and protective factors for aggression. There is also extended coverage of the management of offenders within secure settings and in the community, referring to a wider variety of approaches and the incorporation of technology. This book will be of considerable interest to academics, practitioners, and students engaged with understanding and/or treating violence and aggression, sex crime, forensic psychology, and the assessment, treatment, and management of offenders.

Among women’s health concerns, reproductive issues, both prenatal and postpartum, hold particular prominence. Yet despite the many programs dedicated to improving women’s reproductive health, maternal and infant morbidity and mortality rates in minority communities remain unchanged—or have increased. Confronting this alarming statistic head-on, Reducing Racial/Ethnic Disparities in Reproductive and Perinatal Outcomes is the first book systematically examining public health interventions designed toward meeting this important and elusive goal. Its contributors offer the best thinking and practice on this complicated topic, clarifying the relationship between evidence-based medicine and evidence-based public health and its potential for increasing parity, considering interventions in the multiple contexts of women’s lives, reviewing the evidence base for each program or initiative featured, and describing methodologies for evaluating interventions. The resulting volume advocates for an integrative lifespan approach, including topics related to: Family planning STI and HIV/AIDS screening and treatment Smoking cessation and reducing exposure to environmental smoke Preconceptional well-woman care Depression screening and treatment Labor/delivery approaches and intrapartum care Emerging prenatal care interventions, from centering pregnancy to doula support For professionals and graduate students in psychiatry, psychology, sociology, women’s health, and public health, Reducing Racial/Ethnic Disparities in Reproductive and Perinatal Outcomes reframes a set of ongoing issues and guides the reader toward state-of-the-art solutions.

This text covers the key information necessary to pass Paper B of the postgraduate examination and become a member of the Royal College of Psychiatrists (MRCPsych). It provides candidates with comprehensive coverage of the Paper B syllabus, including information from a wide variety of sources to save candidates crucial time during exam revision. The content is accessible and presented in manageable sections, highlighting key information using tables, lists and graphics. This text is essential for psychiatry trainees revising for their written examinations and is also suitable for individuals/healthcare professionals with an interest in psychiatry and a desire to learn more.